In the per-protocol analysis , strokes were reduced by 34 % ( P = 0.026 ) , total mortality by 28 % ( P = 0.001 ) , cardiovascular event by 37 % ( P < 0.001 ) and heart failure by 72 % ( P < 0.001 ) .